Multiple Sclerosis

last authored:

 

Introduction

Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease characterized by distinct episodes of neurologic deficits. It is the most common demyelinating disorder, affecting 1:1000.

 

 

 

The Case of...

a simple case introducing clincial presentation and calling for a differential diagnosis. To get students thinking.

return to top

 

 

Causes and Risk Factors

MS can occur at any age, though onset during childhood and over the age of 50 is relatively rare.

women are affected twice as often as men.

Genetic factors are linked to MS; the risk is 15x higher in people with first-degree relatives with MS, and even higher for monozygotic twins. Linkage has been established to the DR2 extended haplotype, though other loci can also be involved.

 

Environmental factors are also involved, though latitude effects appear to be linked primarily to genes.

return to top

 

 

Pathophysiology

MS is characterized by multiple white matter lesions caused by an immune response against the myelin sheath. Current evidence suggests CD4+ Th1 cells react against myelin components and secrete cytokines such as IFN-γ that activates macrophages.

CD4+, CD8+ cells, and macrophages are all present, along with antibodies, though their role is less clear.

 

It is unclear how the autoimmune reaction begins, though microbial triggers and genetic factors are thought to play a role. Initially, there is relative preservation of axons with loss of oligodendrocytes. Over time, astrocytes become reactive and proliferate.

 

MS Plaques

While plaques can occur throughout the CNS, certain patterns are commonly observed. Plaques usually occur throughout CNS white matter, though can also be found on the brainstem surface and along the spinal cord.

They often present alongside the ventricles and can follow the course of paraventricular veins. They frequently develop in the optic nerves and chiasm, brain stem ascending and descending tracts, cerebellum, and spinal cord

Plaques can range in size from microscopic to involving large portions of the centrum semiovale.

At the microscopic level, plaques have sharply defined borders.

In active plaques, there is evidence of ongoing myelin breakdown, with many macrophages containing lipid-rich PAS-positive debris. Quiescent plaques have little to no myelin, few oligodendrocytes, an abundance of glial cells, and decreased axons number.

 

In shadow plaques, there is a blurring between healthy and diseased tissue.

 

Plaques can be well demarcated and centred on blood vessels, with or without immunoglobulin and complement deposition, or they can be less well demarcated and not centred on vessels. This suggests distinct mechanisms at work, as the same type of plaques is normally found within the same individual

return to top

 

 

Signs and Symptoms

Some plaques can be clinically silent in people with or without MS.

  • history
  • physical exam

History

 

fatigue and depression

  • unilateral visual impairment during the course of a few days is a common initial presentation
  • involvement of the brain stem produces cranial nerve signs, ataxia, nystagmus, and internuclear ophthalmoplegia from interruption of the medial longitudinal fasciculus.
  • spinal cord lesions lead to motor and sensory impairment of the trunk and limbs, spacticity, and difficulties in voluntary control of bladder symptoms

Pain

  • paresthesias, dysesthesia, hyperesthesia
  • trigeminal neuralgia
  • dysesthetic pain
  • back pain
  • visceral pain
  • painful tonic spasms
  • may be migratory

Useless hand syndrome: loss of discriminatory function and proprioreception.

Autonomic

  • loss of bladder, bowel, sexual dysfunction

 

 

Physical Exam

Cranial nerves:

  • optic neuritis (afferent pupillary defect)
  • diplopia (internuclear opthalmoplegia)
  • trigeminal neuralgia
  • other cranial nerve defects

Sensory (most common)

  • Lhermitte's sign: electrical shock felt down spine during neck flexion
  • loss of sensation/proprioreception

Motor

  • spasms
  • weakness
  • spacticity
  • hyperreflexia

Cerebellar

  • loss of balance and incoordination
  • action tremor
  • slurred speech

Cognitive Assessment

 

cognitive impairment

speed is thought to be one of the primary impairments, but these can be difficult to assess.

 

return to top

 

 

Investigations

Lab Tests

 

Increased protein in CSF

Oligobanding on CSF protein electrophoresis due to B cell proliferation within the CNS. Epitopes are widely variable

Moderate pleocytosis in the CSF in 1/3 of cases

Diagnostic Criteria

The 2005 Revised MacDonald criteria (Polman et al, 2005):

clinical attacks

objective lesions

additional requirements

2 or more

2 or more

none

2 or more

1

dissemination is space by MRI, or
2 or more lesions on MRI consistent with MS plus +CSF, or

await further attack implicating other site

1

2 or more

dissemination is space by MRI, or
second clinical attack

1

1

dissemination is space by MRI, or
2 or more lesions on MRI consistent with MS plus +CSF, AND
dissemination is time by MRI, or second clinical attack

0

1 or more

disease progression for one year, AND 2/3 of the following:

  • positive brain MRI
  • positive spinal cord MRI
  • positive CSF

 

  • lab investigations
  • diagnostic imaging

Lab Investigations

Imaging

 

MRI of head/spine has a sensitivity of 90%

 

A positive MRI has 3/4 of the following (Tintore et al, 2000):

  • 1 Gd-enhancing brain or cord lesion, or 9 T2 hyperintense brain/cord lesions
  • 1 or more brain infratentorial or cord lesions
  • 1 or more juxtacortical lesions
  • 3 or more periventricular lesions

 

return to top

 

 

Differential Diagnosis

Inflammatory diseases:

Infections

granulomatous diseases

myelin diseases

other

return to top

 

 

Treatments

Medications

Steroids can be used in acute situations

 

Interferon beta: immunomodulating; shots daily or weekly

 

Tysabri (natalizumab) antibody against integrin α4; appears to prevent crossing of immune cells across the blood brain barrier

 

return to top

 

 

Consequences and Course

There are a number of patterns of MS

 

relapsing-remitting (about 85% at presentation): Half of people will have more progression after some years, with an average of one attack per year.

primary progressive (about 15% at presentation)

secondary progressive: Occurs after a period of relapsing-remitting

progressive-relapsing: relapsing course, but with overall progression

 

Exacerbations are new/worsening neurological deficits that lasts longer than 24 hours and is not due to fever or other systemic processes.

Pseudo-exacerbations ae transient neurological signs and symptoms due to illness (ie UTI), heat, or exertion. They typically resolve with removal of trigger.

return to top

 

 

The Case of...

Case #2 - a small story wrapping it all up and asking about esp management.

return to top

 

 

Additional Resources

Polman CH et al. 2005. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of Neurology. 58(6):840-6.

Tintore et al, 2000. Am J Radiography 21:702-706.

return to top

 

 

Topic Development

created:

authors:

editors:

reviewers:

 

return to top